United States · FDA National Drug Code directory
Trikafta
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51167-445_b63ac090-8d8b-43a0-82d1-558127f2d598
- Product NDC
- 51167-445
- Form
- KIT
- Composition / generic term
- Elexacaftor, Tezacaftor, and Ivacaftor
- Labeler
- Vertex Pharmaceuticals Incorporated
- Marketing category
- NDA
- Marketing start / end (source format)
- 20230426
- Source listing expiry
- 20271231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 4 PACKAGE in 1 CARTON (51167-445-01) / 1 KIT in 1 PACKAGE * 1 GRANULE in 1 PACKET (51167-545-07) * 1 GRANULE in 1 PACKET (51167-645-07) · 51167-445-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →